安克創新(300866.SZ):與亞馬遜雲的聯合創新實驗室在智能廣吿投放等領域展開合作
格隆匯5月11日丨安克創新(300866.SZ)於2023年5月10日10:00-12:00召開2022年度網上業績説明會,問答環節中,就“公司與亞馬遜雲科技建立聯合創新實驗室,AI如何賦能業務?是否有已經應用的?”,公司表示,我們與亞馬遜雲的聯合創新實驗室在智能廣吿投放等領域展開合作,實現了自動廣吿調價競價機制,將廣吿投放從人工/規則模式轉變為智能模式,優化廣吿展示效果,效率提升30%以上;並通過應用亞馬遜雲科技的機器學習服務AmazonSageMaker,幫助更好地實現產品規劃決策、產品質量優化、銷售運營優化和營銷投放策略優化等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.